Exercise and load modification versus corticosteroid injection versus ‘wait and see’ for persistent gluteus medius/minimus tendinopathy (the LEAP trial): a protocol for a randomised clinical trial

Table 4 Primary and Secondary Outcome measures

Primary outcomes	Measurement	Baseline	4 weeks	8 weeks	12 weeks	26 weeks	52 weeks
Average Pain over the last week	11-point Pain Numeric Rating Scale (NRS), with terminal descriptors of 0 = ‘no pain’ and 10 = ‘worst pain possible’	√	√	√	√	√	√
Perceived overall change in condition of Hip	Global Rating of Change Scale		√	√	√	√	√
Secondary Outcomes	Measurement
Global Impact of pain	Lateral Hip Pain Questionnaire	√	√	√	√	√	√
Function	Patient Specific Functional Scale	√	√	√	√	√	√
Quality of life	EuroQoL	√	√	√	√	√	√
Muscle strength	Static painfree abductor muscle strength	√		√
Muscle Function	Active Lag Abductor Muscles	√		√
Pain Catastrophising	Pain Catastophising Scale	√	√	√	√	√	√
Depression	PHQ-9	√	√	√	√	√	√
Pain and Function	VISA-G	√	√	√	√	√	√
Pain Self-Efficacy	Pain Self-Efficacy Questionnaire	√	√	√	√	√	√
Physical Activity Levels	Active Australia Survey	√	√	√	√	√	√
Economic Costs	OCC-Q	√				√	√

EuroQoL European quality of life questionnaire, PHQ-9 patient health questionnaire-9; OCC-Q osteoarthritis costs and consequences questionnaires

ISSN: 1471-2474